InMed Pharmaceuticals (INM) Q1 2023 Earnings

15MayConfirmed
Sep 22
Nov 22
Q4 2022
Q1 2023
-14.03
-9.55
-5.08
-0.6

Details

Expected EPS
N/A
Actual EPS
-0.6
Surprise EPS
-0.6
Surprise Percent
+∞%

Description

InMed Pharmaceuticals (INM) has reported earnings of -0.6 per share for Q1 2023.

0 Comments

Share your thoughts